Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Oct 2026 for Rapport Therapeutics, Inc., €1.1M.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Abraham N. Ceesay: trading record in brief
This profile gathers the share dealings of Abraham N. Ceesay in Rapport Therapeutics, Inc. We count 2 filings; the first trade dates from 29 June 2026 and the latest from 6 October 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 6 October 2026 came the latest disclosure, a transaction for €1.1M in Rapport Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Abraham N. Ceesay
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
39,470 shares@ US$31.15CommonSEC144:0001958244-26-000649
99,480 shares@ US$40.390.25% mcap100.0% of flowCommonSEC144:0001958244-26-000411
2 of 2 declarations
